Carisbamate in essential tremor: Brief report of a proof of concept study

Movement Disorders

Volumn 25, Issue 5, 2010, Pages 634-638

  Elble, Rodger J ^a   Biondi, David M ^b   Ascher, Steve ^b   Wiegand, Frank ^c   Hulihan, Joseph ^b  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Ortho McNeil Pharmaceutical Incorporated   (United States)

^c JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Adults; Carisbamate; Essential tremor; RWJ 333369

Indexed keywords

ANTICONVULSIVE AGENT; CARISBAMATE; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AFFECT; APPENDICITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; ESSENTIAL TREMOR; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SIDE EFFECT; SOMNOLENCE; TREMOR; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CARBAMATES; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ESSENTIAL TREMOR; FEMALE; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 77951242392     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22872     Document Type: Article

References (10)

1. Lyons KE, Pahwa R. Pharmacotherapy of essential tremor: an overview of existing and upcoming agents. CNS Drugs 2008;22:1037-1045.
2. Yao C, Doose DR, Novak G, Bialer M. Pharmacokinetics of the new antiepileptic and CNS drug RWJ-333369 following single and multiple dosing to humans. Epilepsia 2006;47:1822-1829.
3. Faught E, Holmes GL, Rosenfeld WE, et al. Randomized, controlled, dose-ranging trial of carisbamate for partial-onset seizures. Neurology 2008;71:1586-1593.
4. Sperling M, Greenspan A, Cramer J, et al. Carisbamate as adjunctive treatment of partial onset seizures in adults in two international, randomized, placebo-controlled trials. Epilepsia 2009 [Epub ahead of print].
5. Liu Y, Yohrling GJ, Wang Y, et al. Carisbamate, a novel neuromodulator, inhibits voltage-gated sodium channels and action potential firing of rat hippocampal neurons. Epilepsy Res 2009;83:66-72.
6. Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord 1998;13 (Suppl 3):2-23.
7. Fahn S, Tolosa E, Marin C. Clinical rating scale for tremor. In: Jankovic J, Tolosa E, editors. Parkinson's disease and movement disorders, second ed. Baltimore: Williams & Wilkins; 1993. p 225-234.
8. McNair DM, Lorr M, Droppleman LF. Manual: Profile of Mood States. San Diego CA: Educational and Industrial Testing Service; 1971.
9. Radloff LS. The CES-D scale: a self-report depression scale for research in the general depression scale for research in the general population. J Appl Psychol Meas 1977;1:385-401.
10. Tröster AI, Pahwa R, Fields JA, Tanner CM, Lyons KE. Quality of life in Essential Tremor Questionnaire (QUEST): development and initial validation. Parkinsonism Relat Disord 2005;11:367-373.